nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Urinary retention—Ibandronate—osteoporosis	0.021	0.022	CcSEcCtD
Alvimopan—Anaemia—Ergocalciferol—osteoporosis	0.02	0.0209	CcSEcCtD
Alvimopan—Constipation—Calcium Acetate—osteoporosis	0.0171	0.0179	CcSEcCtD
Alvimopan—Benazepril—MTHFR—osteoporosis	0.0168	0.363	CrCbGaD
Alvimopan—Flatulence—Etidronic acid—osteoporosis	0.0158	0.0166	CcSEcCtD
Alvimopan—Hypokalaemia—Pamidronate—osteoporosis	0.0158	0.0165	CcSEcCtD
Alvimopan—Quinapril—ACE—osteoporosis	0.0157	0.34	CrCbGaD
Alvimopan—Urinary tract disorder—Raloxifene—osteoporosis	0.0153	0.016	CcSEcCtD
Alvimopan—Connective tissue disorder—Raloxifene—osteoporosis	0.0152	0.0159	CcSEcCtD
Alvimopan—Urethral disorder—Raloxifene—osteoporosis	0.0151	0.0159	CcSEcCtD
Alvimopan—Urinary tract disorder—Ibandronate—osteoporosis	0.0151	0.0158	CcSEcCtD
Alvimopan—Constipation—Ergocalciferol—osteoporosis	0.0151	0.0158	CcSEcCtD
Alvimopan—Connective tissue disorder—Ibandronate—osteoporosis	0.015	0.0158	CcSEcCtD
Alvimopan—Urethral disorder—Ibandronate—osteoporosis	0.015	0.0157	CcSEcCtD
Alvimopan—Anaemia—Etidronic acid—osteoporosis	0.0148	0.0155	CcSEcCtD
Alvimopan—Hypokalaemia—Zoledronate—osteoporosis	0.0144	0.0151	CcSEcCtD
Alvimopan—Malnutrition—Estropipate—osteoporosis	0.0139	0.0146	CcSEcCtD
Alvimopan—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.0139	0.0145	CcSEcCtD
Alvimopan—Flatulence—Estropipate—osteoporosis	0.0137	0.0143	CcSEcCtD
Alvimopan—Benazepril—ACE—osteoporosis	0.0137	0.296	CrCbGaD
Alvimopan—Flatulence—Alendronate—osteoporosis	0.0135	0.0141	CcSEcCtD
Alvimopan—Back pain—Estropipate—osteoporosis	0.0134	0.0141	CcSEcCtD
Alvimopan—Malnutrition—Ibandronate—osteoporosis	0.0133	0.014	CcSEcCtD
Alvimopan—Flatulence—Raloxifene—osteoporosis	0.0133	0.0139	CcSEcCtD
Alvimopan—Flatulence—Ibandronate—osteoporosis	0.0131	0.0138	CcSEcCtD
Alvimopan—Back pain—Ibandronate—osteoporosis	0.0129	0.0135	CcSEcCtD
Alvimopan—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.0128	0.0134	CcSEcCtD
Alvimopan—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.0127	0.0133	CcSEcCtD
Alvimopan—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.0127	0.0133	CcSEcCtD
Alvimopan—Anaemia—Alendronate—osteoporosis	0.0126	0.0132	CcSEcCtD
Alvimopan—Urinary tract disorder—Risedronate—osteoporosis	0.0124	0.013	CcSEcCtD
Alvimopan—Connective tissue disorder—Risedronate—osteoporosis	0.0124	0.013	CcSEcCtD
Alvimopan—Urethral disorder—Risedronate—osteoporosis	0.0124	0.013	CcSEcCtD
Alvimopan—Anaemia—Ibandronate—osteoporosis	0.0123	0.0129	CcSEcCtD
Alvimopan—Urinary tract disorder—Pamidronate—osteoporosis	0.0118	0.0124	CcSEcCtD
Alvimopan—Connective tissue disorder—Pamidronate—osteoporosis	0.0118	0.0123	CcSEcCtD
Alvimopan—Urethral disorder—Pamidronate—osteoporosis	0.0117	0.0123	CcSEcCtD
Alvimopan—Dyspepsia—Etidronic acid—osteoporosis	0.0115	0.0121	CcSEcCtD
Alvimopan—Malnutrition—Ethinyl Estradiol—osteoporosis	0.0113	0.0118	CcSEcCtD
Alvimopan—Constipation—Etidronic acid—osteoporosis	0.0112	0.0117	CcSEcCtD
Alvimopan—Malnutrition—Risedronate—osteoporosis	0.011	0.0115	CcSEcCtD
Alvimopan—Back pain—Ethinyl Estradiol—osteoporosis	0.0109	0.0114	CcSEcCtD
Alvimopan—Flatulence—Risedronate—osteoporosis	0.0108	0.0113	CcSEcCtD
Alvimopan—Urinary tract disorder—Zoledronate—osteoporosis	0.0108	0.0113	CcSEcCtD
Alvimopan—Connective tissue disorder—Zoledronate—osteoporosis	0.0108	0.0113	CcSEcCtD
Alvimopan—Urethral disorder—Zoledronate—osteoporosis	0.0107	0.0112	CcSEcCtD
Alvimopan—Back pain—Risedronate—osteoporosis	0.0106	0.0111	CcSEcCtD
Alvimopan—Malnutrition—Pamidronate—osteoporosis	0.0104	0.0109	CcSEcCtD
Alvimopan—Anaemia—Risedronate—osteoporosis	0.0101	0.0106	CcSEcCtD
Alvimopan—Back pain—Pamidronate—osteoporosis	0.0101	0.0106	CcSEcCtD
Alvimopan—Dyspepsia—Estropipate—osteoporosis	0.00997	0.0105	CcSEcCtD
Alvimopan—Dyspepsia—Alendronate—osteoporosis	0.00982	0.0103	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Estropipate—osteoporosis	0.00978	0.0103	CcSEcCtD
Alvimopan—Constipation—Estropipate—osteoporosis	0.00969	0.0102	CcSEcCtD
Alvimopan—Dyspepsia—Raloxifene—osteoporosis	0.00966	0.0101	CcSEcCtD
Alvimopan—Anaemia—Pamidronate—osteoporosis	0.00964	0.0101	CcSEcCtD
Alvimopan—Dyspepsia—Ibandronate—osteoporosis	0.00956	0.01	CcSEcCtD
Alvimopan—Constipation—Alendronate—osteoporosis	0.00954	0.01	CcSEcCtD
Alvimopan—Malnutrition—Zoledronate—osteoporosis	0.00953	0.00999	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00947	0.00993	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00938	0.00983	CcSEcCtD
Alvimopan—Constipation—Ibandronate—osteoporosis	0.00929	0.00974	CcSEcCtD
Alvimopan—Back pain—Zoledronate—osteoporosis	0.00921	0.00966	CcSEcCtD
Alvimopan—Malnutrition—Conjugated Estrogens—osteoporosis	0.00917	0.00962	CcSEcCtD
Alvimopan—Constipation—Calcitriol—osteoporosis	0.00909	0.00954	CcSEcCtD
Alvimopan—Flatulence—Conjugated Estrogens—osteoporosis	0.00904	0.00948	CcSEcCtD
Alvimopan—Back pain—Conjugated Estrogens—osteoporosis	0.00887	0.0093	CcSEcCtD
Alvimopan—Anaemia—Zoledronate—osteoporosis	0.0088	0.00923	CcSEcCtD
Alvimopan—Urinary tract disorder—Estradiol—osteoporosis	0.00833	0.00873	CcSEcCtD
Alvimopan—Connective tissue disorder—Estradiol—osteoporosis	0.00829	0.00869	CcSEcCtD
Alvimopan—Urethral disorder—Estradiol—osteoporosis	0.00827	0.00867	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00793	0.00831	CcSEcCtD
Alvimopan—Dyspepsia—Risedronate—osteoporosis	0.00788	0.00826	CcSEcCtD
Alvimopan—Constipation—Ethinyl Estradiol—osteoporosis	0.00785	0.00823	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Risedronate—osteoporosis	0.00773	0.0081	CcSEcCtD
Alvimopan—Constipation—Risedronate—osteoporosis	0.00766	0.00803	CcSEcCtD
Alvimopan—Dyspepsia—Pamidronate—osteoporosis	0.00749	0.00785	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00735	0.0077	CcSEcCtD
Alvimopan—Malnutrition—Estradiol—osteoporosis	0.00734	0.0077	CcSEcCtD
Alvimopan—Constipation—Pamidronate—osteoporosis	0.00728	0.00763	CcSEcCtD
Alvimopan—Flatulence—Estradiol—osteoporosis	0.00723	0.00758	CcSEcCtD
Alvimopan—Back pain—Estradiol—osteoporosis	0.0071	0.00744	CcSEcCtD
Alvimopan—Dyspepsia—Zoledronate—osteoporosis	0.00684	0.00717	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00671	0.00704	CcSEcCtD
Alvimopan—Constipation—Zoledronate—osteoporosis	0.00665	0.00697	CcSEcCtD
Alvimopan—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00659	0.00691	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00646	0.00678	CcSEcCtD
Alvimopan—Constipation—Conjugated Estrogens—osteoporosis	0.0064	0.00671	CcSEcCtD
Alvimopan—Dyspepsia—Estradiol—osteoporosis	0.00527	0.00553	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Estradiol—osteoporosis	0.00517	0.00542	CcSEcCtD
Alvimopan—Constipation—Estradiol—osteoporosis	0.00512	0.00537	CcSEcCtD
